SEC Form S-8 POS filed by Chiasma, Inc.

As filed with the Securities and Exchange Commission on August 6, 2021

Registration No. 333-253885

Registration No. 333-237204

Registration No. 333-230162

Registration No. 333-210259

Registration No. 333-205773

---

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

---

 

POST-EFFECTIVE AMENDMENT NO. 1 TO

Form S-8 Registration No. 333-253885

Form S-8 Registration No. 333-237204

Form S-8 Registration No. 333-230162

Form S-8 Registration No. 333-210259

Form S-8 Registration No. 333-205773

UNDER THE SECURITIES ACT OF 1933

 

---

 

CHIASMA, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Chiasma, Inc. 2008 Stock Incentive Plan

Chiasma, Inc. 2015 Stock Option and Incentive Plan

Chiasma, Inc. 2015 Employee Stock Purchase Plan

Inducement Stock Option Award (April 22, 2020)

(Full title of the plans)

---

140 Kendrick Street, Building C East

Needham, Massachusetts 02494

(Name and address of agent for service)

(617)-928-5300

(Telephone number, including area code, of agent for service)

---

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”).

DEREGISTRATION OF SECURITIES

This Post-Effective Amendment No. 1 (this “Post-Effective Amendment”) relates to the following Registration Statements on Form S-8 (each, a “Registration Statement,” and collectively, the “Registration Statements”), filed with the Securities and Exchange Commission (the “SEC”) by Chiasma, Inc. (the “Registrant”):

On August 5, 2021, pursuant to the terms of an Agreement and Plan of Merger (the “Merger Agreement”) dated as of May 4, 2021 by and among Amryt Pharma plc, a public limited company incorporated under the laws of England and Wales (“Amryt”), Acorn Merger Sub, Inc., a Delaware corporation and an indirect wholly owned subsidiary of Amryt (“Merger Sub”), and the Registrant, Merger Sub merged with and into the Registrant, with the Registrant surviving the merger as an indirect, wholly owned subsidiary of Amryt (the “Merger”).

 

As a result of the Merger, the Registrant has terminated any and all offerings of its securities pursuant to the Registration Statements. In accordance with an undertaking made by the Registrant in the Registration Statements to remove from registration, by means of a post-effective amendment, any of the securities registered under the Registration Statements that remain unissued at the termination of the offerings, the Registrant hereby removes from registration all securities registered but unsold under such Registration Statements, if any, as of the date hereof.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to be signed on its behalf by the undersigned, thereunto duly authorized, in Dublin, Ireland on August 6, 2021.

No other person is required to sign this Post-Effective Amendment in reliance upon Rule 478 under the Securities Act of 1933.

---